Skip to content

Amryt Pharma plc

CIK 0001783010

← back to feed
Revenue (TTM)
$222.54M
+21.9% YoY FY Dec 2021
Net Income (TTM)
$1M
+101.0% YoY FY Dec 2021
EPS Diluted (TTM)
$0.00
+100.0% YoY FY Dec 2021
Gross Margin
52.3%
FY Dec 2021
Operating Margin
-17.3%
FY Dec 2021
Net Margin
0.4%
FY Dec 2021
Free Cash Flow (TTM)
—
FY Dec 2021
Cash
$113.03M
FY Dec 2021
Total Debt
—
FY Dec 2021
Shares Outstanding
319.81M sh
FY Dec 2021

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings